152 related articles for article (PubMed ID: 28362708)
21. Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas.
Nili F; Tavakoli M; Izadi Mood N; Saffar H; Sarmadi S
Iran J Pathol; 2020; 15(2):81-85. PubMed ID: 32215023
[TBL] [Abstract][Full Text] [Related]
22. Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas.
Mukhopadhyay S; Katzenstein AL
Am J Clin Pathol; 2012 Nov; 138(5):703-11. PubMed ID: 23086771
[TBL] [Abstract][Full Text] [Related]
23. Expression of Markers of Müllerian Clear Cell Carcinoma in Primary Cervical and Vaginal Gastric-type Adenocarcinomas.
Talia KL; Wong RW; McCluggage WG
Int J Gynecol Pathol; 2019 May; 38(3):276-282. PubMed ID: 29901522
[TBL] [Abstract][Full Text] [Related]
24. Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.
Ju B; Wang J; Yang B; Sun L; Guo Y; Hao Q; Wu J
Int J Gynecol Pathol; 2018 Jul; 37(4):388-396. PubMed ID: 28796747
[TBL] [Abstract][Full Text] [Related]
25. Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Chernock RD; El-Mofty SK; Becker N; Lewis JS
Am J Surg Pathol; 2013 Aug; 37(8):1215-22. PubMed ID: 23681073
[TBL] [Abstract][Full Text] [Related]
26. Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
Beck J; Miller MA; Frank C; DuSold D; Ramos-Vara JA
Vet Pathol; 2017 Sep; 54(5):767-774. PubMed ID: 28578631
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma.
Lim D; Ip PP; Cheung AN; Kiyokawa T; Oliva E
Am J Surg Pathol; 2015 Aug; 39(8):1061-9. PubMed ID: 25871622
[TBL] [Abstract][Full Text] [Related]
28. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
Sangoi AR; Soslow RA; Teng NN; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
[TBL] [Abstract][Full Text] [Related]
30. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
Zhang B; Lin J; Da J
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):499-503. PubMed ID: 26705042
[TBL] [Abstract][Full Text] [Related]
32. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Yan W; Liang Z; Xiong H; Chen K
Tumour Biol; 2015 Sep; 36(10):8085-92. PubMed ID: 25982999
[TBL] [Abstract][Full Text] [Related]
33. Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study.
Ku FC; Wu RC; Yang LY; Tang YH; Chang WY; Yang JE; Wang CC; Jung SM; Lin CT; Chang TC; Chao A; Lai CH
J Formos Med Assoc; 2018 Feb; 117(2):117-125. PubMed ID: 28389144
[TBL] [Abstract][Full Text] [Related]
34. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
[TBL] [Abstract][Full Text] [Related]
35. Napsin A: Another milestone in the subclassification of ovarian carcinoma.
Köbel M; Duggan MA
Am J Clin Pathol; 2014 Dec; 142(6):735-7. PubMed ID: 25389324
[No Abstract] [Full Text] [Related]
36. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
Kadivar M; Boozari B
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
[TBL] [Abstract][Full Text] [Related]
37. Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.
Kim MY; Go H; Koh J; Lee K; Min HS; Kim MA; Jeon YK; Lee HS; Moon KC; Park SY; Kim WH; Chung DH
Histopathology; 2014 Aug; 65(2):195-206. PubMed ID: 24479710
[TBL] [Abstract][Full Text] [Related]
38. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
39. A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.
Köbel M; Kalloger SE; Carrick J; Huntsman D; Asad H; Oliva E; Ewanowich CA; Soslow RA; Gilks CB
Am J Surg Pathol; 2009 Jan; 33(1):14-21. PubMed ID: 18830127
[TBL] [Abstract][Full Text] [Related]
40. Carcinomas of ovary and lung with clear cell features: can immunohistochemistry help in differential diagnosis?
Howell NR; Zheng W; Cheng L; Tornos C; Kane P; Pearl M; Chalas E; Liang SX
Int J Gynecol Pathol; 2007 Apr; 26(2):134-40. PubMed ID: 17413979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
